Identification of SHMT2 as a Potential Prognostic Biomarker and Correlating with Immune Infiltrates in Lung Adenocarcinoma

Figure 6

Immunohistochemistry (IHC) of SHMT2 expression in LUAD tissues and corresponding normal tissues based on The Human Protein Atlas (HPA). (a–c) Normal lung (T-28000) tissue and (d–f) lung (T-28000) tumor tissue.